Sunday, June 8, 2025

Creating liberating content

Private sector lender HDFC Bank has reduced its benchmark lending

Related News

Private sector lender HDFC Bank has reduced its benchmark lending rates following the Reserve Bank of India’s (RBI) unexpected decision on Friday to cut the repo rate by 50 basis

Indore couple missing in Meghalaya NEW DELHI: Meghalaya minister Alexander Hek on Sunday emphasised his state’s commitment to justice in the Indore couple case, amid a growing demand seeking transfer

Trinamool Congress (TMC) MP Mahua Moitra recently got married to senior advocate and former BJD MP Pinaki Misra in Germany.A video of the two leaders dancing to the song “Raat

Indian fashion e-commerce giant Myntra has set its sights on international expansion, beginning with Singapore, where it launched its Myntra Global platform last month to cater to the growing Indian

Brainteasers are an excellent method to test your intelligence and improve your mental acuity. They assess not just your IQ but also your capacity for critical thought, logical reasoning, and

Nine of India’s ten most-valued companies collectively added Rs 1,00,850.96 crore to their market capitalisation last week, lifted by broadly positive sentiment in the equity markets. Reliance Industries and HDFC

Trending News

Private sector lender HDFC Bank has reduced its benchmark lending rates following the Reserve Bank of India’s (RBI) unexpected decision on Friday to cut the repo rate by 50 basis

India’s top listed real estate firms recorded a blockbuster performance last fiscal, with property sales surging past Rs 1.62 lakh crore, marking a jump of over 20% from the previous

NEW DELHI: Indian startups are struggling to grow due to limited domestic investment and restrictive government regulations, warned industry veteran and Aarin Capital Chairman Mohandas Pai, calling for urgent policy

The public feud between US President Donald Trump and Tesla CEO Elon Musk has turned into both a political and a Wall Street drama, raising investor concerns and exposing the

DGTR suggested measures to protect domestic manufacturers from unfair import pricing. (AI image) India has slapped anti-dumping duties on insoluble sulphur imported from China and Japan. Additionally, the country has

NEW DELHI: Market sentiment this week will be shaped by global trends, key inflation data, and foreign investor activity. Investors will also keep a close watch on monsoon progress and

Government bans sale and manufacture of 35 fixed-dose combination drugs; full list here |

Word Count: 715 | Estimated Reading Time: 4 minutes


Government bans sale and manufacture of 35 fixed-dose combination drugs; full list here

35 fixed-dose combination drugs that include painkillers, nutrition supplements and anti-diabetics will not be sold and manufactured as directed by the apex drugs regulatory body CDSCO. Fixed-dose combination drugs are those which contain a combination of two or more active pharmaceutical ingredients (APIs) in a fixed ratio.
These are also known as the cocktail medicines and comprise painkillers, supplements, and Fertility combinations like Nefopam Hydrochloride 30mg+, Paracetamol 325mg tablets, Cefiximeip 200mg + Ofloxacin IP 200mg Lactic acid bacillus 60 million spores tablets, etc. Some of these combinations pose a great risk to human health.
For example, taking glimepiride 1 mg with metformin 500 mg at the same time isn’t ideal because they work best when timed differently. Metformin is usually taken after food to reduce the risk of stomach upset, while glimepiride, being a sulfonylurea, should be taken before meals to help stimulate insulin release just as your blood sugar starts to rise. Taking them together can reduce their effectiveness and may increase the risk of side effects.
In a communication sent on April 11, Drugs Controller General of India (DCGI) Dr Rajeev Raghuvanshi referred to the letter issued by his office on January 2013 where concerns were raised regarding the grant of manufacturing licenses for sale of FDC drugs that fall under the definition of a “New Drug” in the country without due approval from DCGI. “It has come to the notice of this directorate that certain FDC drugs have been licensed for manufacture, sale, and distribution without prior evaluation of safety and efficacy as per the provision of NDCT Rules 2019 under the Drugs and Cosmetics Act 1940. This poses a serious risk to public health and safety,” the letter stated. The approval of such unapproved FDCs compromises patient safety and may lead to adverse drug reactions, drug interactions, and other health hazards due to the absence of scientific validation, the letter underlined.
Here’s the list of medicine

“Irrational combination of medicines correctly banned by CDSCO”

Welcoming the move, Dr Deep Dutta, Endocrinologist, Diabetes Super-specialist; Clinical Researcher urged people to be more careful of these mocktail medicines. “Irrational combination of medicines correctly banned by CDSCO. Hope the order is implemented strictly. Need more awareness among doctors & patients. There should be some logic, scientific basis, proof of safety & efficacy based on the kinetics of the medicines before they are combined,” he posted on X.





Source link

Most Popular Articles

Sign In

Welcome ! Log into Your Account